Pfizer's (NYSE:PFE) stock up by 7.7% over the past three months. However, we decided to study the company's mixed-bag of ...

Key Points Pfizer and Novo Nordisk have underperformed the market over the past year.But both should remain major players in ...

Pfizer (NYSE:PFE) has had a rough month with its share price down 2.9%. ... Stock prices are usually driven by a company’s financial performance over the long term, ...

Pfizer: Performance Is Improving, But Secular Issues Persist (Rating Upgrade) Aug. 23, 2024 4:29 AM ET Pfizer Inc. (PFE) Stock , PFE:CA Stock PFE , PFE:CA 17 Comments 3 Likes KM Capital ...

The pharma giant's future financial performance is a matter of debate. Pfizer ( PFE -1.29% ) is a stock that everyone's familiar with, but that doesn't mean that everyone agrees you should buy it.

The company reaffirmed its financial guidance for 2025, which it had announced in December 2024. Pfizer expects total revenues between $61.0 billion and $64.0 billion.

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Pfizer: Financial Performance Dissected Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, ...

Pfizer due to report earnings before the bell Tuesday. The pharma giant has consistently outpaced Wall Street’s expectations, beating them 14 of the last 15 quarters. Shares of PFE have lost ...

One reason for Pfizer's weaker financial performance this year is due to shelter-in-place measures related to the COVID-19 pandemic that have slowed demand for new prescriptions and vaccinations.

Pfizer, buoyed by a huge jump in sales for its COVID-19 vaccine and solid performance across most of the company, is hiking its 2021 financial forecast sharply after blowing past Wall Street ...

Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating yesterday. David Risinger has gi ...